Cargando…
Central Nervous System Involvement as Outcome Measure for Clinical Trials Efficacy in Myotonic Dystrophy Type 1
Increasing evidences indicate that in Myotonic Dystrophy type 1 (DM1 or Steinert disease), an autosomal dominant multisystem disorder caused by a (CTG)n expansion in DMPK gene on chromosome 19q13. 3, is the most common form of inherited muscular dystrophy in adult patients with a global prevalence o...
Autores principales: | Simoncini, Costanza, Spadoni, Giulia, Lai, Elisa, Santoni, Lorenza, Angelini, Corrado, Ricci, Giulia, Siciliano, Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575726/ https://www.ncbi.nlm.nih.gov/pubmed/33117249 http://dx.doi.org/10.3389/fneur.2020.00624 |
Ejemplares similares
-
Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study
por: Baldanzi, Sigrid, et al.
Publicado: (2016) -
Hard ways towards adulthood: the transition phase in young people with myotonic dystrophy
por: Baldanzi, Sigrid, et al.
Publicado: (2016) -
Muscle exercise in limb girdle muscular
dystrophies: pitfall and advantages
por: SICILIANO, GABRIELE, et al.
Publicado: (2015) -
Relationship between neuropsychological impairment and grey and white matter changes in adult-onset myotonic dystrophy type 1
por: Baldanzi, Sigrid, et al.
Publicado: (2016) -
Outcome Measures for Central Nervous System Evaluation in Myotonic Dystrophy Type 1 May Be Confounded by Deficits in Motor Function or Insight
por: Hamilton, Mark J., et al.
Publicado: (2018)